Physician profile
John Neill
NPI 1114330180
$2,955.64
in general payments reported to CMS, 2019-2025
24 companies · $1,093 in 2025
The $1,093 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $346 · 2022: $281 · 2023: $425 · 2024: $810 · 2025: $1,093.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,329.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,328.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $602.09 | 2025 | Afx2 Bifurcated Endograft System |
| Medtronic, INC. | $487.84 | 2021-2025 | Endurant Iis, Corevalve Evolut R, Ellipsys Vascular Access System |
| Silk Road Medical, INC. | $393.90 | 2021-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Penumbra, INC. | $326.65 | 2022-2025 | Penumbra System, Indigo System |
| W. L. Gore & Associates, INC. | $288.70 | 2021-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Excluder Aaa Endoprosthesis, Gore Excluder Iliac Branch Endoprosthesis |
| Lemaitre Vascular, INC. | $165.98 | 2022-2025 | Artegraft Vascular Graft, Pruitt F3 Carotid Shunt, Hydro Lemaitre Valvulotome |
| Inari Medical, INC. | $136.06 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Kerecis Limited | $107.12 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Boston Scientific Corporation | $62.67 | 2025 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Philips North America LLC | $46.92 | 2025 | Coronary Other |
| Dilon Technologies, INC. | $44.90 | 2025 | Hemoblast Bellows |
| Smith+Nephew, INC. | $43.21 | 2022-2023 | Renasys Go V2 Home |
| Elutia, INC. | $38.95 | 2022 | |
| Merck Sharp & Dohme LLC | $26.52 | 2025 | Keytruda |
| Abbott Laboratories | $24.85 | 2025 | Navitor |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $24.08 | 2024 | Surgiflo Hemostatic Matrix, Surgicel Nu-Knit, Evarrest |
| Bard Peripheral Vascular, INC. | $19.06 | 2023 | |
| Solventum Corporation | $18.82 | 2024 | Activ.A.C. |
| Abiomed | $18.00 | 2025 | |
| Biocomposites INC | $16.47 | 2023 | Stimulan |
| Terumo Medical Corporation | $16.39 | 2023 | Azur Cx Detachable |
| Atricure, INC. | $16.34 | 2021 | |
| Getinge USA Sales, LLC | $15.43 | 2022 | |
| Stryker Corporation | $14.69 | 2024 | Sonopet Iq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Neill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.